Literature DB >> 12473551

S-nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty.

Zoltan Kaposzta1, Andrew Clifton, Jane Molloy, John F Martin, Hugh S Markus.   

Abstract

BACKGROUND: The major complication of carotid angioplasty is embolic stroke, which may occur after balloon inflation and deflation or in the early postintervention period. Platelet adhesion and aggregation to the angioplasty site with subsequent embolization seems to plays a major role in early postangioplasty embolization and stroke. During this period, asymptomatic embolic signals can be detected in patients by transcranial Doppler ultrasound despite aspirin and heparin treatment. S-nitrosoglutathione (GSNO) is a nitric oxide donor that appears to have relative platelet specificity. We evaluated its effectiveness in reducing embolization after carotid angioplasty. METHODS AND
RESULTS: Sixteen patients undergoing carotid angioplasty and stenting for symptomatic > or =70% internal carotid artery stenosis were randomized in a double-blind manner to GSNO or placebo given after surgery for 90 minutes. All patients were pretreated with aspirin and given heparin for 24 hours after the procedure. Transcranial Doppler recordings were made from the ipsilateral middle cerebral artery for 1 hour before treatment and at 0 to 3, 6, and 24 hours after treatment. GSNO resulted in a rapid reduction in the frequency of embolic signals of 95% at 0 to 3 hours and 100% at 6 hours (P=0.007 and P=0.01 versus placebo, respectively). In the placebo group, 2 patients experienced ipsilateral stroke after the angioplasty. No cerebrovascular events occurred in the GSNO group.
CONCLUSIONS: S-nitrosoglutathione was highly effective in rapidly reducing the frequency of embolic signals after endovascular treatment for symptomatic high-grade carotid stenosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12473551     DOI: 10.1161/01.cir.0000041251.07332.28

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  S-Nitrosoglutathione administration ameliorates cauda equina compression injury in rats.

Authors:  Anandakumar Shunmugavel; Mushfiquddin Khan; Marcus M Martin; Anne G Copay; Brian R Subach; Thomas C Schuler; Inderjit Singh
Journal:  Neurosci Med       Date:  2012-09-25

Review 2.  S-nitrosoglutathione.

Authors:  Katarzyna A Broniowska; Anne R Diers; Neil Hogg
Journal:  Biochim Biophys Acta       Date:  2013-02-14

Review 3.  S-nitrosothiols as selective antithrombotic agents - possible mechanisms.

Authors:  M P Gordge; F Xiao
Journal:  Br J Pharmacol       Date:  2010-03-08       Impact factor: 8.739

Review 4.  Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.

Authors:  Kirtiman Srivastava; Philip M W Bath; Ulvi Bayraktutan
Journal:  Cell Mol Neurobiol       Date:  2011-12-25       Impact factor: 5.046

5.  Stimulation of functional recovery via the mechanisms of neurorepair by S-nitrosoglutathione and motor exercise in a rat model of transient cerebral ischemia and reperfusion.

Authors:  Harutoshi Sakakima; Mushfiquddin Khan; Tajinder S Dhammu; Anandakumar Shunmugavel; Yoshihiro Yoshida; Inderjit Singh; Avtar K Singh
Journal:  Restor Neurol Neurosci       Date:  2012       Impact factor: 2.406

6.  Brain Embolism Monitoring with Transcranial Doppler Ultrasound.

Authors:  Viken L. Babikian; Christine A. Wijman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-07

7.  S-nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats.

Authors:  Mushfiquddin Khan; Harutoshi Sakakima; Tajinder S Dhammu; Anandakumar Shunmugavel; Yeong-Bin Im; Anne G Gilg; Avtar K Singh; Inderjit Singh
Journal:  J Neuroinflammation       Date:  2011-07-06       Impact factor: 8.322

8.  Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact.

Authors:  Mushfiquddin Khan; Yeong-Bin Im; Anandakumar Shunmugavel; Anne G Gilg; Ramanpreet K Dhindsa; Avtar K Singh; Inderjit Singh
Journal:  J Neuroinflammation       Date:  2009-11-04       Impact factor: 8.322

9.  In Situ Microparticles Loaded with S-Nitrosoglutathione Protect from Stroke.

Authors:  Marianne Parent; Ariane Boudier; Julien Perrin; Claude Vigneron; Philippe Maincent; Nicolas Violle; Jean-François Bisson; Isabelle Lartaud; François Dupuis
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

10.  Potential therapeutic action of nitrite in sickle cell disease.

Authors:  Nadeem Wajih; Swati Basu; Anuj Jailwala; Hee Won Kim; David Ostrowski; Andreas Perlegas; Crystal A Bolden; Nancy L Buechler; Mark T Gladwin; David L Caudell; Elaheh Rahbar; Martha A Alexander-Miller; Vidula Vachharajani; Daniel B Kim-Shapiro
Journal:  Redox Biol       Date:  2017-05-10       Impact factor: 11.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.